A 10-year investment period changes the way I look at ASX shares.

I am less interested in what might move next month and more interested in whether the business can become much larger, stronger, or more valuable over time.

The three ASX 300 shares below all look capable of doing that, in my opinion.

Catapult Sports Ltd (ASX: CAT)

Catapult Sports is one of the more interesting growth shares on the ASX.

The company provides technology used by elite sports teams to track athlete performance, manage workload, analyse video, and improve decision-making.

That may sound niche, but I think the long-term opportunity is attractive.

Professional sport keeps becoming more data-driven. Clubs and leagues are spending more on tools that can help them reduce injuries, improve training, support coaching decisions, and find small performance advantages.

What I like about Catapult Sports is that its products can become part of the way teams operate. Once performance staff, coaches, and athletes are using the platform, the relationship can become deeper and stickier over time.

This is still a growth business, so investors should expect some volatility. Catapult needs to keep converting its customer base and recurring revenue into stronger profits.

But over 10 years, I think the company has a genuine chance to become a much larger global sports technology business.

SiteMinder Ltd (ASX: SDR)

SiteMinder is another ASX 300 share I would be happy to buy and hold.

The company provides software for hotels, helping them manage bookings, distribution channels, direct sales, payments, and online visibility.

I like this business because it sits behind a problem that hotel operators face every day.

Hotels need to sell rooms across multiple platforms, manage pricing, reduce friction, and compete for guests in a digital travel market. That can be difficult, especially for smaller and independent operators. SiteMinder gives hotels the tools to handle more of that complexity in one place.

The travel sector will always have cycles. Weak consumer spending, economic slowdowns, and global shocks can affect hotel demand.

But the long-term shift toward digital hotel commerce looks hard to reverse. I think more accommodation providers will need better technology to compete.

And if SiteMinder keeps expanding its platform and improving monetisation, I think it could be a rewarding 10-year holding.

Bega Cheese Ltd (ASX: BGA)

Bega Cheese is a very different type of ASX 300 share.

It is tied to food, dairy, branded products, and everyday consumer demand. That gives it a more defensive feel than many smaller growth shares.

What interests me is that the Vegemite owner appears to have a clearer earnings improvement pathway.

Its FY26 EBITDA guidance is $222 million to $227 million. Looking further out, the company has outlined an FY31 EBITDA target of more than $310 million.

That growth is expected to be supported by investment in areas such as milk-based beverages, yoghurt, and Tatura cream cheese capability.

There are still things to watch, including input costs, supermarket pricing pressure, execution, and competition.

But if management can deliver on its targets, Bega could look like a much stronger business in 10 years.

Foolish takeaway

I think these are the kinds of ASX 300 shares that can reward investors who are willing to look beyond the next earnings update.

Each business still has plenty to prove, which is why I would not treat any of them as risk-free blue-chip holdings. But that is also where the opportunity sits.

Catapult, SiteMinder, and Bega Cheese all have clear ways to become better businesses over time, whether through deeper customer relationships, stronger platforms, improved efficiency, or expansion into higher-value areas.

For a 10-year holding period, that is what I want to see. The share price may not reward investors evenly along the way, but I think the long-term direction looks attractive.

The post 3 ASX 300 shares I would buy and hold for 10 years appeared first on The Motley Fool Australia.

More reading

• ASX consumer staples shares are quietly surging while the rest of the market stalls. Here is why
• 2 ASX growth shares down 50%+ that I’d buy with $2,000 in July
• These ASX tech shares crashed hard. Could they double from here?
• How should I invest my money in FY27?
• This beaten-down ASX tech share could rise almost 50%

Motley Fool contributor Grace Alvino has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has positions in and has recommended Catapult Sports and SiteMinder. The Motley Fool Australia has positions in and has recommended Catapult Sports and SiteMinder. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Evolution Mining Ltd (ASX: EVN) shares had a tough session on Thursday.

The gold miner’s shares ended the day almost 4% lower at $11.34 after investors reacted negatively to its fourth-quarter update.

While this is disappointing, Bell Potter thinks it could have created a buying opportunity for investors.

What is the broker saying?

Bell Potter was pleased with the company’s update despite production coming in softer than expected. It commented:

EVN released its June quarter 2026 production and cost report which, in our view, was a solid final quarter from EVN and was its second-best quarter of FY26. While both gold and copper production came in below our forecasts, Ernest Henry returned to full production following the weak March quarter and delivered its best quarterly performance of FY26. For the June quarter, group production was 179.7koz gold and 18.8kt copper (vs BPe 189.0koz gold and 19.6kt copper). 

The broker also highlights that the ASX gold stock has released part of its guidance for FY 2027, revealing that its costs are expected to rise and its investments will increase. However, it is comfortable with this. It said:

EVN released high-level elements of FY27 guidance. Overall, it pointed to steady production, but higher sustaining capital, higher AISC on general cost inflation and higher CAPEX on growth projects. It also flagged increased spending on exploration and on life-of-mine studies. While higher than our prior forecasts, we are comfortable the organic investment options are lower risk and higher returning than M&A in the current market. EVN has an excellent track record on this front, where returns on invested capital at Cowal, Ernest Henry and Mungari have been high.

Should you buy Evolution Mining shares?

According to the note, Bell Potter has retained its buy rating on Evolution Mining shares with a trimmed price target of $15.10 (from $16.45).

Based on its current share price, this implies potential upside of 33% for investors over the next 12 months.

In addition, Bell Potter is forecasting an attractive 4.4% dividend yield in FY 2027. This boosts the total potential return beyond 37%.

Commenting on its investment thesis, the broker said:

EPS changes on this update are -6% for FY26, -15% for FY27 and -4% for FY28. We have trimmed our production forecasts and increased our AISC forecasts in line with initial guidance for FY27. We have also lifted our capital expenditure assumptions in line with the outlook. As a result, we also trim our dividend forecasts on the lower free cash flow. 

EVN offers fully unhedged gold and copper exposure via a portfolio of high quality, long-life assets in Tier 1 jurisdictions, overseen by a high-quality management team. EVN has stated its intention to pass growing free cash flows on to shareholders.

The post Could Evolution Mining shares rise 33%? appeared first on The Motley Fool Australia.

More reading

• 5 things to watch on the ASX 200 on Thursday
• Evolution Mining posts record FY26 cash flow
• 5 things to watch on the ASX 200 on Wednesday
• Here are the top 10 ASX 200 shares today
• 5 things to watch on the ASX 200 on Friday

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

Chemist Warehouse is one of the most recognisable businesses on Australia’s streets. It’s owned by Sigma Healthcare Ltd (ASX: SIG), which isn’t a household name, but I think Sigma is an appealing ASX share to buy.

The country’s leading pharmacy business may be best known for Chemist Warehouse, but it also has other elements to the company including Amcal, Discount Drug Stores and a pharmaceutical wholesale business.

However, with Chemist Warehouse making up a significant majority of the company’s earnings, I think it’s the right place for investors to focus because of three different reasons.

Excellent performance by the existing store network

When there are many different growth areas of a business to consider, I think it’s important to see that the core business is performing strongly for shareholders, which is happening at Sigma Healthcare.

The core Chemist Warehouse network in Australia is doing very well and continues to drive the value of the intrinsic value of the business higher.

In early May, the business gave a trading update which revealed the Australian Chemist Warehouse network delivered total sales growth of 16.7% year-over-year for the period of 1 July 2025 to 30 April 2026. This was mostly powered by like-for-like (LFL) sales growth of 14.4%, which is an excellent rate of growth, in my view, for a large retail business.

Thankfully, the company has tailwinds such as Australia’s ageing and growing population. Plus, pharmacies are a huge market, so there is still a lot of market share the company could claim thanks to its scale benefits and low prices.

I expect Chemist Warehouse will be able to expand its Australian network with more stores at a pleasing pace over the rest of this decade.

Growth of the international network

Australia is not the only growth avenue for the business. The ASX share also operates in New Zealand, Ireland, Dubai and online in China.

Its international store network delivered 24.7% total sales growth and LFL sales growth of 14.4% for the period 1 July 2025 to 31 March 2026. I expect the company’s store networks in New Zealand and Ireland to steadily expand.

Excitingly, Sigma is also going to enter the UK market thanks to a joint venture agreement with Greenlight Healthcare. Greenlight has 22 stores in and around London – Sigma will acquire a 75% interest in a number of stores, with the other 25% continuing to be held by Greenlight.

Under that joint venture, Sigma will licence the Chemist Warehouse brand and intellectual property, and provide retail support (including ranging, store layout, inventory management and marketing support).

Phase one will rebrand up to five stores initially, with the option for more stores if the first phase is successful.

Improving profit margins

In my view, the ASX share has an exciting future of sales growth ahead, but profit growth could be even better because the company’s increasing scale helps profit margins rise. Additional revenue dollars are becoming increasingly profitable in each reporting period.

For example, in the first half of FY26, the company reported that revenue grew by 14.9% to $5.5 billion.

Normalised operating profit (EBIT) grew strongly, rising by 18.7% to $582.9 million – faster than sales growth.

The normalised net profit after tax (NPAT) grew 19.2% to $392 million – faster than the EBIT growth.

It’s normally net profit growth that investors value a business on, so the profit growth looks very appealing to me. The company can use this net profit to fund more growth, pay down debt and/or pay rising dividends to shareholders.

Overall, there’s a lot to like about this ASX share, though it’s not the only name I’d love to have in my portfolio.

The post 3 reasons why the ASX share owner of Chemist Warehouse is a buy appeared first on The Motley Fool Australia.

More reading

• Leading brokers name 3 ASX shares to buy today
• Here are the top 10 ASX 200 shares today
• Here are the top 10 ASX 200 shares today
• Why I want to own these ASX shares brokers rate as buys
• How should I invest my money in FY27?

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.